F
Forus
Automating prescription-to-approval workflows to help patients access medicine at no cost
About Forus
Forus is a healthcare technology innovator that functions as an AI-native operating system designed to bridge the gap between scientific breakthroughs and patient access. Originally founded as Tandem, the company focuses on removing the logistical and administrative obstacles that delay treatment, such as complex prior authorization processes and fragmented pharmacy routing. By providing a centralized platform that handles the end-to-end journey of a prescription, Forus aims to ensure that the "last mile" of healthcare is as efficient as the scientific research that precedes it.
Read full description
The company's target market includes the entire healthcare ecosystem: patients who need faster access to medicine, clinicians who are overwhelmed by administrative documentation, and biopharma companies looking to streamline drug launches. Unlike traditional healthcare software that adds costs to providers, Forus operates on a unique model where its automation tools are provided for free to healthcare professionals. Its primary value proposition lies in reclaiming clinical time for physicians and reducing the 10-to-15-year timeline typically required to bring and distribute new drugs to market.
Forus leverages advanced artificial intelligence to manage clinical workflows both during and after patient visits. Its technology includes automated prescription writing, real-time clinical decision support, and AI-driven coding assistants that integrate seamlessly with existing Electronic Health Record (EHR) systems. By automating these "administrative" steps, Forus transforms the clinical visit from a paperwork-heavy encounter into a patient-centered experience, using data-driven insights to accelerate medical approval and delivery at a global scale.
At a glance
- Status
- Operational
- Founded
- 2023
- Headquarters
- New York City, United States
- Employees
- 211
- Open positions
- 7
- Dealroom signal
- 92.7/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, Health Platform
- Sector
- Biotech & Life Sciences, Health Care Information Technology, Medical Professionals, Medical & Healthcare, Core AI, Verified Unicorns and $1B Exits, Tech for Hospitals and Clinics, Tech for Medical Professionals
- Technology
- Artificial Intelligence
- Business model
- Marketplace & ecommerce
- Client focus
- b2b, b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | May 2026 | $123M | $1B | Pear Ventures · Accel · Redpoint · General Catalyst | ↗ |
| SERIES AOther financing | Jan 2024 | $30M | $120M | BoxGroup · General Catalyst | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Forus is 160K monthly website visits, up 14.3% over the last three months. Forus's team declined 27% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Series B and later5 investors entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Forus on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Forus’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.














